Labcorp to present multiple abstracts across precision oncology at the 2024 asco annual meeting

Abstracts offer insights into precision oncology diagnostics for triple-negative breast cancer, liquid biopsy and machine learning for tumor profiling burlington, n.c. , may 30, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, will present several abstracts at the 2024 american society of clinical oncology (asco) annual meeting in chicago (may 31 – june 4, 2024).
LH Ratings Summary
LH Quant Ranking